Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADPT | AMGN | GILD | CELG | VRTX |
| Company | Adaptive Biotechnologies Corp | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.61 | 265.72 | 65.50 | 108.01 | 393.52 |
| High | 2.73 | 271.68 | 66.35 | 108.59 | 397.95 |
| Low | 2.56 | 265.72 | 64.63 | 107.27 | 393.49 |
| Last | 2.69 | 269.99 | 65.10 | 108.24 | 396.60 |
| Change | +0.08 | +0.61 | -0.17 | +0.11 | -1.10 |
| % Change | +3.07% | +0.23% | -0.26% | +0.10% | -0.28% |
| Volume | 138,685 | 237,986 | 3,176,087 | 191,230,496 | 92,002 |
| 20-Day Average Volume | 2,077,665 | 2,045,186 | 6,581,909 | 16,188,930 | 913,458 |
| Previous Close | 2.61 | 269.38 | 65.27 | 108.13 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.70 | 270.03 | 68.30 | 108.17 | 401.25 |
| 20-Day Raw Stochastic | 42.93% | 43.56% | 11.99% | 63.25% | 19.53% |
| 20-Day Relative Strength | 44.04% | 46.35% | 30.60% | 64.69% | 42.17% |
| Weighted Alpha | -61.99 | +9.91 | -23.09 | +46.30 | +14.57 |
| Today's Opinion | 88% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.71% since 04/19/24 | +0.70% since 04/19/24 | -1.65% since 04/19/24 | -1.97% since 11/13/19 | +0.68% since 04/19/24 |
| Low | 2.36 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 393.00 on 04/25/24 |
| High | 2.73 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -6.08% since 03/26/24 | -3.89% since 03/26/24 | -9.32% since 03/26/24 | +5.14% since 10/18/19 | -5.14% since 03/26/24 |
| Low | 2.28 on 04/19/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 3.34 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -31.52% since 01/26/24 | -13.14% since 01/26/24 | -17.43% since 01/26/24 | +13.63% since 08/20/19 | -7.72% since 01/26/24 |
| Low | 2.28 on 04/19/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 4.34 on 02/28/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -39.15% since 10/26/23 | +0.40% since 10/26/23 | -16.36% since 10/26/23 | +14.14% since 05/20/19 | +9.87% since 10/26/23 |
| Low | 2.28 on 04/19/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 5.49 on 12/28/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 378,690 | 144,488,960 | 81,266,176 | 77,035,920 | 102,789,152 |
| Shares Outstanding, K | 145,092 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 170,280,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -225,250,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 45,780,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -69,440,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.25 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 02/14/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 29.82 |